Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine ...

In the longer term, DGX stock is up 10.5% on a YTD basis, outpacing SPX’s 2.9% dip. Moreover, shares of Quest Diagnostics have surged 29.3% over the past 52 weeks, compared to the 9.8% return ...

Quest Diagnostics Inc.’s DGX investments in Advanced ... A strong focus on operational excellence is highly encouraging for the stock. Meanwhile, unfavorable solvency and a fierce competitive ...

Analysts have set 12-month price targets for Quest Diagnostics, revealing an average target of $179.44, a high estimate of ...

Quest Diagnostics adjusts Q1 revenue & EPS outlook due to weather impact, projects 4-5% CAGR revenue growth beyond 2025. Read ...

This was the stock's third consecutive day of losses.

Thrivent Financial for Lutherans decreased its stake in Quest Diagnostics Incorporated (NYSE:DGX – Free Report) by 7.1% ...

Shares of Quest Diagnostics Inc. DGX shed 1.39% to $173.12 Monday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index SPX falling 2.70% to 5,614. ...

Quest Diagnostics teams up with Google Cloud to ... likely played influential roles in the 11.57% stock price increase over the past quarter. The broader... Aveanna (AVAH) was a big mover last ...

stock has rallied 25.2% compared with the industry’s 2.9% growth and the S&P 500 composite’s 10.6% rise. The renowned provider of diagnostic information services has a market capitalization of $18.38 ...